Virus News and Research

Latest Virus News and Research

First U.S. case of Ebola diagnosed in Texas

The patient, who reportedly took a Sept. 20 commercial flight from Liberia to Dallas, represents the first case in the current outbreak diagnosed outside of Africa.

1 Oct 2014

Viewpoints: Mergers causing health costs to rise; reauthorize CHIP; Obamacare's influence on politics

Health care costs are going up, and there's a lot of debate about why. Is it the high cost of drugs or our aging population?

1 Oct 2014

Rapid and coordinated response helps control Ebola outbreak in Nigeria

The Ebola outbreak in Nigeria appears to be nearing a possible end thanks to a rapid response coordinated by Nigeria's Emergency Operations Center with assistance from international partners, including the U.S. Centers for Disease Control and Prevention (CDC).

1 Oct 2014

Mymetics' innovative HIV vaccine candidate to enter new preclinical trial

Mymetics Corporation, a pioneer in the research and development of virosome-based vaccines to prevent transmission of human infectious diseases across mucosal membranes, announced today that its innovative HIV vaccine candidate will enter a new preclinical trial to confirm excellent results obtained in a previous trial.

30 Sep 2014

Gut microbe in patients may tip doctors about SCID

Many people recognize "the bubble boy" as an unusual character from a "Seinfeld" episode or a John Travolta movie.

30 Sep 2014

Rwanda is Ebola free, says Ministry of Health

The Ministry of Health would like to inform Rwandans and all visitors to Rwanda that Rwanda is Ebola free. The lab results of the patient who was reported in the media this past week were negative for the Ebola Virus Disease.

30 Sep 2014

Johnson & Johnson inks definitive deal to acquire Alios BioPharma

Johnson & Johnson today announced a definitive agreement to acquire Alios BioPharma, Inc., a privately held clinical stage biopharmaceutical company focused on developing therapies for viral diseases, for approximately $1.75 billion in cash.

30 Sep 2014

Bridgestone Group to donate $1M to combat Ebola outbreak in Liberia

The Bridgestone Group (Bridgestone) today announced it will donate one million dollars (USD) to critical efforts underway in Liberia and the region to combat the Ebola outbreak.

30 Sep 2014

New approach to solve global challenges in food security, emerging diseases and biodiversity loss

Solving global challenges in food security, emerging diseases and biodiversity loss requires evolutionary thinking, argues a new study published online in Science Express that was co-authored by Bruce Tabashnik of the University of Arizona College of Agriculture and Life Sciences.

30 Sep 2014

Protein Sciences releases Flublok influenza vaccine for the 2014/2015 season

Protein Sciences Corporation, manufacturer of the revolutionary Flublok influenza vaccine, announced today that doses of the vaccine have been released and are now available for shipment.

29 Sep 2014

Early detection of cancers on the horizon with supersensitive nanodevice

Extremely early detection of cancers and other diseases is on the horizon with a supersensitive nanodevice being developed at The University of Alabama in Huntsville in collaboration with The Joint School of Nanoscience and Nanoengineering in Greensboro, NC.

29 Sep 2014

Study correlates HPV vaccine series completion among young US women

According to a recent study in the journal Human Vaccines & Immunotherapeutics, only 60% of young US women who received the first dose of the human papilloma virus (HPV) vaccine went on to complete the three-dose vaccine series.

29 Sep 2014

Canadian government committed to prevent, detect, and respond to infectious disease outbreaks

The Honourable Rona Ambrose, Minister of Health, committed to continued efforts to strengthen global health security at the Global Health Security Agenda (GHSA) meeting in Washington, DC.

27 Sep 2014

Many gay, bisexual men complacent about HIV testing

Gay and bisexual men say HIV is the No. 1 health issue facing their community, but just 30 percent say they were tested for the virus within the last year as recommended. Another 30 percent say they have never been tested, according to a survey by the Kaiser Family Foundation.

26 Sep 2014

CDC forecast: Ebola epidemic could infect more than 1.4 million people by January end

The Ebola epidemic could claim hundreds of thousands of lives and infect more than 1.4 million people by the end of January, according to a statistical forecast released this week by the U.S. Centers for Disease Control and Prevention.

26 Sep 2014

Research findings provide clues for design of future HIV vaccine

Scientists at The Scripps Research Institute have described how a single family of antibodies that broadly neutralizes different strains of HIV has evolved remarkably diverse structures to attack a vulnerable site on the virus.

26 Sep 2014

Triple-punch of antibodies prevents, wipes out hepatitis C infection in laboratory mice

A triple-punch of antibodies both prevented hepatitis C infection and wiped out the disease after it had established itself in laboratory mice, according to a study led by Princeton University researchers.

26 Sep 2014

Scientists analyze current situation of malaria and dengue fever in Himalayas

Research by Nepalese and German scientists from the Nepal Health Research Council, Goethe University and the LOEWE Biodiversity and Climate Research Centre analyzes the current situation of these diseases in the Himalayan country of Nepal and highlights how they profit from climate change and globalization.

26 Sep 2014

NIH, CSU scientists provide evidence that supports camels as primary carrier of MERS-CoV

National Institutes of Health and Colorado State University scientists have provided experimental evidence supporting dromedary camels as the primary reservoir, or carrier, of Middle East respiratory syndrome coronavirus (MERS-CoV).

25 Sep 2014

Inovio, GeneOne to advance DNA-based Ebola vaccine into phase I clinical trial

Inovio Pharmaceuticals, Inc. announced it will advance its DNA vaccine for Ebola into a phase I clinical trial in a collaboration with GeneOne Life Science Inc., an international DNA vaccine manufacturer in which Inovio holds a minority interest.

24 Sep 2014